228 related articles for article (PubMed ID: 33719199)
1. Tuberculosis infection and disease in South African adolescents with perinatally acquired HIV on antiretroviral therapy: a cohort study.
Frigati LJ; Wilkinson KA; le Roux S; Brown K; Ruzive S; Githinji L; Petersen W; Belard S; Cotton MF; Myer L; Zar HJ
J Int AIDS Soc; 2021 Mar; 24(3):e25671. PubMed ID: 33719199
[TBL] [Abstract][Full Text] [Related]
2. Cardiopulmonary dysfunction in perinatally HIV-infected South African adolescents on antiretroviral therapy: baseline findings from the Cape Town Adolescent Antiretroviral Cohort.
Githinji LN; Mahtab S; Zühlke L; Lawrenson J; Myer L; Gray D; Zar H
J Int AIDS Soc; 2019 Jul; 22(7):e25340. PubMed ID: 31291058
[TBL] [Abstract][Full Text] [Related]
3. Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study.
Lawn SD; Brooks SV; Kranzer K; Nicol MP; Whitelaw A; Vogt M; Bekker LG; Wood R
PLoS Med; 2011 Jul; 8(7):e1001067. PubMed ID: 21818180
[TBL] [Abstract][Full Text] [Related]
4. Chest X-ray interpretation does not complement Xpert MTB/RIF in diagnosis of smear-negative pulmonary tuberculosis among TB-HIV co-infected adults in a resource-limited setting.
Nakiyingi L; Bwanika JM; Ssengooba W; Mubiru F; Nakanjako D; Joloba ML; Mayanja-Kizza H; Manabe YC
BMC Infect Dis; 2021 Jan; 21(1):63. PubMed ID: 33435896
[TBL] [Abstract][Full Text] [Related]
5. Performance of the Abbott RealTi
Scott L; David A; Noble L; Nduna M; Da Silva P; Black A; Venter F; Stevens W
J Clin Microbiol; 2017 Aug; 55(8):2491-2501. PubMed ID: 28592547
[TBL] [Abstract][Full Text] [Related]
6. Intensified tuberculosis case-finding in HIV-positive adults managed at Ethiopian health centers: diagnostic yield of Xpert MTB/RIF compared with smear microscopy and liquid culture.
Balcha TT; Sturegård E; Winqvist N; Skogmar S; Reepalu A; Jemal ZH; Tibesso G; Schön T; Björkman P
PLoS One; 2014; 9(1):e85478. PubMed ID: 24465572
[TBL] [Abstract][Full Text] [Related]
7. Incidence of Tuberculosis Among HIV-Positive Individuals Initiating Antiretroviral Treatment at Higher CD4 Counts in the HPTN 071 (PopART) Trial in South Africa.
Bock P; Jennings K; Vermaak R; Cox H; Meintjes G; Fatti G; Kruger J; De Azevedo V; Maschilla L; Louis F; Gunst C; Grobbelaar N; Dunbar R; Limbada M; Floyd S; Grimwood A; Ayles H; Hayes R; Fidler S; Beyers N
J Acquir Immune Defic Syndr; 2018 Jan; 77(1):93-101. PubMed ID: 29016524
[TBL] [Abstract][Full Text] [Related]
8. An observational study identifying highly tuberculosis-exposed, HIV-1-positive but persistently TB, tuberculin and IGRA negative persons with M. tuberculosis specific antibodies in Cape Town, South Africa.
Kroon EE; Kinnear CJ; Orlova M; Fischinger S; Shin S; Boolay S; Walzl G; Jacobs A; Wilkinson RJ; Alter G; Schurr E; Hoal EG; Möller M
EBioMedicine; 2020 Nov; 61():103053. PubMed ID: 33038764
[TBL] [Abstract][Full Text] [Related]
9. Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community.
Gupta A; Wood R; Kaplan R; Bekker LG; Lawn SD
PLoS One; 2012; 7(3):e34156. PubMed ID: 22479548
[TBL] [Abstract][Full Text] [Related]
10. QuantiFERON conversion following tuberculin administration is common in HIV infection and relates to baseline response.
Esmail H; Thienemann F; Oni T; Goliath R; Wilkinson KA; Wilkinson RJ
BMC Infect Dis; 2016 Oct; 16(1):545. PubMed ID: 27717329
[TBL] [Abstract][Full Text] [Related]
11. HIV viral load as an independent risk factor for tuberculosis in South Africa: collaborative analysis of cohort studies.
Fenner L; Atkinson A; Boulle A; Fox MP; Prozesky H; Zürcher K; Ballif M; Furrer H; Zwahlen M; Davies MA; Egger M;
J Int AIDS Soc; 2017 Jun; 20(1):21327. PubMed ID: 28691438
[TBL] [Abstract][Full Text] [Related]
12. The tuberculin skin test versus QuantiFERON TB Gold® in predicting tuberculosis disease in an adolescent cohort study in South Africa.
Mahomed H; Hawkridge T; Verver S; Abrahams D; Geiter L; Hatherill M; Ehrlich R; Hanekom WA; Hussey GD
PLoS One; 2011 Mar; 6(3):e17984. PubMed ID: 21479236
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Timing of Initiation of Antiretroviral Therapy on Loss to Follow-up in HIV-Tuberculosis Coinfected Patients in South Africa: An Open-Label, Randomized, Controlled Trial.
Yende-Zuma N; Naidoo K
J Acquir Immune Defic Syndr; 2016 Aug; 72(4):430-6. PubMed ID: 26990824
[TBL] [Abstract][Full Text] [Related]
14. Prevalent and incident tuberculosis are independent risk factors for mortality among patients accessing antiretroviral therapy in South Africa.
Gupta A; Wood R; Kaplan R; Bekker LG; Lawn SD
PLoS One; 2013; 8(2):e55824. PubMed ID: 23418463
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study.
Lawn SD; Kerkhoff AD; Vogt M; Wood R
Lancet Infect Dis; 2012 Mar; 12(3):201-9. PubMed ID: 22015305
[TBL] [Abstract][Full Text] [Related]
16. Time-varying age- and CD4-stratified rates of mortality and WHO stage 3 and stage 4 events in children, adolescents and youth 0 to 24 years living with perinatally acquired HIV, before and after antiretroviral therapy initiation in the paediatric IeDEA Global Cohort Consortium.
Desmonde S; Neilan AM; Musick B; Patten G; Chokephaibulkit K; Edmonds A; Duda SN; Malateste K; Wools-Kaloustian K; Ciaranello AL; Davies MA; Leroy V;
J Int AIDS Soc; 2020 Oct; 23(10):e25617. PubMed ID: 33034417
[TBL] [Abstract][Full Text] [Related]
17. "I am not shy anymore": A qualitative study of the role of an interactive mHealth intervention on sexual health knowledge, attitudes, and behaviors of South African adolescents with perinatal HIV.
Bergam S; Sibaya T; Ndlela N; Kuzwayo M; Fomo M; Goldstein MH; Marconi VC; Haberer JE; Archary M; Zanoni BC
Reprod Health; 2022 Dec; 19(1):217. PubMed ID: 36457044
[TBL] [Abstract][Full Text] [Related]
18. Multisystem impairment in South African adolescents with Perinatally acquired HIV on antiretroviral therapy (ART).
Frigati LJ; Brown K; Mahtab S; Githinji L; Gray D; Zühlke L; Nourse P; Stein DJ; Hoare J; Cotton MF; Myer L; Zar HJ
J Int AIDS Soc; 2019 Aug; 22(8):e25386. PubMed ID: 31441211
[TBL] [Abstract][Full Text] [Related]
19. HAART and risk of tuberculosis in HIV-infected South African children: a multi-site retrospective cohort.
Martinson NA; Moultrie H; van Niekerk R; Barry G; Coovadia A; Cotton M; Violari A; Gray GE; Chaisson RE; McIntyre JA; Meyers T
Int J Tuberc Lung Dis; 2009 Jul; 13(7):862-7. PubMed ID: 19555536
[TBL] [Abstract][Full Text] [Related]
20. Time to treatment and patient outcomes among TB suspects screened by a single point-of-care xpert MTB/RIF at a primary care clinic in Johannesburg, South Africa.
Hanrahan CF; Selibas K; Deery CB; Dansey H; Clouse K; Bassett J; Scott L; Stevens W; Sanne I; Van Rie A
PLoS One; 2013; 8(6):e65421. PubMed ID: 23762367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
